Dopamine and Decision-making
05 September 2019
We are interested in understanding how decision-making is influenced by the neurotransmitter dopamine. You are invited to two sessions at our lab (3h each) and you will play computerized tasks. On each session, you will drink orange squash which contains either a dopamine drug (levodopa) or placebo (no drug). The administered dose is low and considered safe. Levodopa has been used in clinical practice to treat Parkinson’s disease for a long time. Payment for your participation will be £60-£70.
Keywords
Ethical approval
This study has been approved by the University College London Research Ethics Committee (Project ID Number): 11285/001
About the researcher
My name is Dr Lorenz Deserno, I am a medical doctor and currently a research associate at University College London. My interest is to understand how certain chemicals in the brain, in particular dopamine, impact on cognitive processes mostly decision-making and learning. I hope to gain knowledge from this research with the long-term goal of improving our understanding of mental symptoms and particularly the diagnoses and treatment of mental disorders.
